Lupron Depot Kit
Product Images NDC 0074-3663

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Lupron Depot (NDC 0074-3663). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Abbvie Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lupron 11 25 Spl 01

An instructional diagram of a Lupron Depot kit syringe, depicting labeled parts including the plunger, finger grip, end stopper, diluent section, middle stoppers, barrel containing Leuprolide Acetate Microsphere Powder, blue line, front stopper, needle and cap, and LupronLoc Safety Device.*

FDA Label Image

Lupron 11 25 Spl 02

An instructional line drawing showing hands assembling a two-part syringe-like device, demonstrating the connection of the plunger and barrel components. The image likely supports reconstitution or preparation steps for Lupron Depot, a prescription drug kit containing leuprolide acetate by AbbVie Inc.*

FDA Label Image

Lupron 11 25 Spl 03

An instructional diagram showing a hand holding a syringe with an arrow pointing upward and a label indicating a 'blue line' near the tip of the syringe. The image appears to demonstrate a step in preparing or using the Lupron Depot leuprolide acetate injection kit by AbbVie Inc.*

FDA Label Image

Lupron 11 25 Spl 04

An instructional illustration showing a hand holding a syringe with arrows pointing left and right near a collar on the syringe plunger, indicating an adjustment or manipulation step for the Lupron Depot kit.*

FDA Label Image

Lupron 11 25 Spl 05

An instructional black-and-white line drawing depicting a hand holding a syringe vertically above a surface, possibly illustrating a step in preparing or administering a medication.*

FDA Label Image

Lupron 11 25 Spl 06

An instructional diagram showing a syringe with an arrow pointing to a specific section near the needle. The diagram indicates that if a blood vessel is injured, blood will be visible in that section of the syringe.*

FDA Label Image

Lupron 11 25 Spl 07

An instructional illustration showing a hand operating a medical device by pulling upward on a syringe-like component with three sequential steps. The third step includes a 'CLICK' sound indicator, demonstrating the proper technique to prepare or activate the device.*

FDA Label Image

Lupron 11 25 Spl 08

Chemical structure of leuprolide acetate, the active ingredient in Lupron Depot. The diagram shows the molecular structure with amino acid residues and functional groups characteristic of this peptide-based drug.*

FDA Label Image

Lupron 11 25 Spl 09

A bar chart comparing percentages of various symptoms—pelvic pain, dyspareunia, pelvic tenderness, induration, and dysmenorrhea—across four time points: baseline, final treatment visit, 6-month follow-up, and 12-month follow-up. Each symptom category shows multiple bars representing percentage changes over time.*

FDA Label Image

Lupron 11 25 Spl 0a

Lupron Depot 11.25 mg for 3-Month administration kit label, containing leuprolide acetate for depot suspension. The label highlights adult use, includes kit contents such as a dual-chamber syringe, plunger, and alcohol swabs, and specifies intramuscular injection. Manufactured by AbbVie Inc., it shows NDC 0074-3663-03 with related lot and expiration details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.